Page 90 - e-book CPG - Bipolar Disorder

CLINICAL PRACTICE GUIDELINES MANAGEMENT OF BIPOLAR DISORDER (2ND ED.)

HR hazard ratio
IDS Inventory of Depressive Symptomatology
IQ Intelligence Quotient
IR immediate release
LAI long-acting injectable
Li lithium
LSMD least squares mean difference
MA meta-analysis
MADRS Montgomery-Asberg Depression Rating Scale
MBCT mindfulness-based cognitive therapy
MDQ Mood disorder questionnaire
MEMS medication event monitoring system
mg milligramme
MSRS Manic State Rating Scale
NMA network meta-analysis
NOS Newcastle-Ottawa Scale
NPRA National Pharmaceutical Regulatory Agency
NS non-significant
OFC olanzapine/fluoxetine combination
QoL quality of life
QIDS-SR Quick Inventory of Depressive Symptomatology Self-Report
OR odds ratio
PANSS Positive and Negative Syndrome Scale
RANZCP Royal Australian and New Zealand College of Psychiatrist
RCT(s) randomised controlled trial(s)
RID Relative Infant Dose
RMS Rapid mood screener
RoB risk of bias
rTMS repetitive transcranial magnetic stimulation
SGA second generation antipsychotic
SMD standard mean difference
SMS short messaging service
SR systematic review
SUCRA Surface Under the Cumulative Ranking Curve
SUD substance use disorder
TAU treatment as usual
TBS theta burst stimulation
TRQ Tablet Routine Questionnaire
WHO World Health Organisation
YMRS Young Mania Rating Scale

76
76